Brief: Celltrion Inc Receives Market Approval From South Korea's Ministry Of Food And Drug Safety For 'Eydenzelt,' Biosimilar Of Eyelea Drug
30/05/2024 03:32
Celltrion Inc 068270.KS :
* CELLTRION INC: RECEIVES MARKET APPROVAL FROM SOUTH KOREA'S
MINISTRY OF FOOD AND DRUG SAFETY FOR 'EYDENZELT,' BIOSIMILAR OF
EYELEA DRUG
Source text for Eikon: ID:
Further company coverage: 068270.KS
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares